Understanding Autoimmune Diseases: Antibody Testing Explained

Added:

Autoimmune Basics
Autoantibody Testing
Rheumatic Diseases
Lupus Prototype
Scleroderma Tests
Disease Spectrum
Causes & Genetics
Overdiagnosis Issue
Testing Methods
RA & Final Summary

Autoimmune Basics

0:11
Playing Section
  • 1

    Defines autoimmune diseases as immune system attacks on the body.

  • 2

    Over 80 diseases exist, often interrelated and multifactorial in origin.

  • 3

    Diagnosis is complex, typically requiring specialist consultation.

The fundamental structure and function of the adaptive immune system, specifically the distinction between antigens and antibodies.
The basic concept of autoimmunity, where the body's immune response is mistakenly directed against its own healthy cells and tissues.
Statistical concepts of diagnostic testing, specifically the definitions of sensitivity, specificity, and what constitutes a false positive.
An introductory understanding of systemic autoimmune disorders, such as Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE).
The clinical diagnostic frameworks (such as ACR/EULAR criteria) that integrate laboratory antibody tests with patient history and physical symptoms.
Reflex testing protocols, such as Extractable Nuclear Antigen (ENA) panels and double-stranded DNA (dsDNA) testing, used to narrow down a broad positive ANA result.
The immunological mechanisms of self-tolerance (central and peripheral tolerance) and the triggers that lead to its breakdown.
Modern therapeutic interventions for autoimmune diseases, including immunosuppressants, DMARDs, and targeted biologic therapies.
30.4K views0likes1:33:23@bio-raddiagnostics9127Original Release: 2013-10-23

Autoimmune diseases are conditions where the body's immune system attacks its own tissues, with over 80 described diseases that are interrelated and often triggered by genetic, environmental, and hormonal factors; laboratory testing for these conditions is complex because autoantibodies frequently appear before clinical symptoms manifest, yet most people with positive autoantibody tests never develop the associated diseases, making widespread screening problematic and emphasizing that testing should be guided by clinical suspicion rather than routine use.